IZZI, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 10.380
AS - Asia 1.784
EU - Europa 1.475
SA - Sud America 308
AF - Africa 55
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 4
Totale 14.014
Nazione #
US - Stati Uniti d'America 10.310
SG - Singapore 791
CN - Cina 339
IT - Italia 314
BR - Brasile 256
RU - Federazione Russa 248
IE - Irlanda 192
VN - Vietnam 173
DE - Germania 168
HK - Hong Kong 159
GB - Regno Unito 113
KR - Corea 109
UA - Ucraina 84
FR - Francia 83
FI - Finlandia 81
JP - Giappone 70
NL - Olanda 48
CA - Canada 44
IN - India 31
SE - Svezia 28
AR - Argentina 23
AT - Austria 22
ID - Indonesia 20
EG - Egitto 18
CZ - Repubblica Ceca 17
MX - Messico 17
TR - Turchia 17
ZA - Sudafrica 16
PL - Polonia 15
ES - Italia 13
BD - Bangladesh 11
BE - Belgio 10
IQ - Iraq 9
PH - Filippine 9
CL - Cile 8
CH - Svizzera 7
GR - Grecia 6
AU - Australia 5
EC - Ecuador 5
KE - Kenya 5
PE - Perù 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
DK - Danimarca 4
DZ - Algeria 4
ET - Etiopia 4
MY - Malesia 4
NP - Nepal 4
RO - Romania 4
SA - Arabia Saudita 4
TW - Taiwan 4
BA - Bosnia-Erzegovina 3
CO - Colombia 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
LT - Lituania 3
PK - Pakistan 3
PY - Paraguay 3
TH - Thailandia 3
AZ - Azerbaigian 2
CR - Costa Rica 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
JO - Giordania 2
LB - Libano 2
LK - Sri Lanka 2
MA - Marocco 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
PT - Portogallo 2
SI - Slovenia 2
TN - Tunisia 2
AL - Albania 1
AO - Angola 1
BW - Botswana 1
GE - Georgia 1
GP - Guadalupe 1
HN - Honduras 1
HR - Croazia 1
KG - Kirghizistan 1
KW - Kuwait 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
NR - Nauru 1
RS - Serbia 1
SV - El Salvador 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 14.014
Città #
Wilmington 2.560
Houston 2.461
Woodbridge 1.581
Singapore 477
Fairfield 407
Ashburn 392
Chandler 325
San Jose 224
Seattle 195
Beijing 170
Dublin 164
Cambridge 159
Hong Kong 155
Ann Arbor 149
New York 131
Medford 115
Rome 107
Santa Clara 87
Council Bluffs 79
The Dalles 77
Dearborn 72
Los Angeles 72
Helsinki 56
Lawrence 54
Ho Chi Minh City 53
Tokyo 49
Lauterbourg 47
Hanoi 44
Buffalo 41
Menlo Park 40
Munich 40
Moscow 39
Boardman 34
San Diego 34
São Paulo 33
Jacksonville 32
Dallas 27
Milan 25
London 21
North Bergen 21
Orem 21
Toronto 19
Chicago 18
Amsterdam 17
Columbus 17
Brno 16
Seoul 16
Brooklyn 14
Stockholm 14
Redwood City 13
Atlanta 12
Istanbul 12
Jakarta 12
Norwalk 12
Cairo 11
Frankfurt am Main 11
Johannesburg 11
Vienna 11
Warsaw 11
Belo Horizonte 10
Brussels 10
Da Nang 10
Manchester 10
Montreal 10
Salt Lake City 10
Chennai 9
Denver 9
Kilburn 9
Nuremberg 9
Phoenix 9
Zhengzhou 9
Boston 8
Haiphong 8
Lappeenranta 8
Mexico City 8
San Francisco 8
Santiago 8
Tōyō 8
Guangzhou 7
Mumbai 7
Nanjing 7
Palo Alto 7
Philadelphia 7
Tsu 7
Athens 6
Bologna 6
Poplar 6
Porto Alegre 6
Redondo Beach 6
Washington 6
City of London 5
Kunming 5
Nairobi 5
Naples 5
Rio de Janeiro 5
Biên Hòa 4
Elk Grove Village 4
Engelhard 4
Hounslow 4
Kathmandu 4
Totale 11.410
Nome #
Chronic dopaminergic treatment in restless legs syndrome: Does it affect the autonomic nervous system? 503
Predicting seizures in untreated temporal lobe epilepsy using point-process nonlinear models of heartbeat dynamics 482
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population: further data and comments 476
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease 456
Optic Nerve dysfunction in obstructive sleep apnea: An electrophysiological study 445
Effective treatment of nocturnal frontal lobe epilepsy with lacosamide: a report of two cases 429
Physical activity contradictorily affects bone mineral density in obstructive sleep apnea patients at different ages 425
Beta-amyloid and phosphorylated tau metabolism changes in narcolepsy over time 423
Obstructive sleep apnoea as a risk factor for osteopenia and osteoporosis in the male population 420
Does continuous positive airway pressure treatment affect autonomic nervous system in patients with severe obstructive sleep apnea? 384
Cerebral glucose metabolism in idiopathic REM sleep behavior disorder is different from tau-related and α-synuclein-related neurodegenerative disorders: A brain [18F]FDG PET study 376
Folic acid supplements during pregnancy in specific clinical settings: What dowe know about epilepsy? 373
MicroRNA expression is dysregulated in narcolepsy: A new evidence? 366
Daytime autonomic activity in idiopathic rapid eye movement sleep behavior disorder: a preliminary study 365
Effects of adjunctive perampanel on sleep quality, daytime somnolence and cognition in refractory focal epilepsy: Further data 364
Obstructive sleep apnoea and bone health 353
Continuous positive airway pressure treatment may improve optic nerve function in obstructive sleep apnea: An electrophysiological study 314
Sleep apnoeas may represent a reversible risk factor for amyloid-β pathology 311
Postural and vestibular changes related to CPAP treatment in moderate-to-severe OSA patients: a 12-month longitudinal study 285
Long-term efficacy and safety of lacosamide and levetiracetam monotherapy in elderly patients with focal epilepsy: A retrospective study 278
Obstructive sleep apnea may induce orexinergic system and cerebral β-amyloid metabolism dysregulation: is it a further proof for Alzheimer's disease risk? 267
Feasibility of automated detection of sleep apnea using implantable pacemakers and defibrillators: a comparison with simultaneous polysomnography recording 257
Heart rate variability in untreated newly diagnosed temporal lobe epilepsy: Evidence for ictal sympathetic dysregulation 252
Cognitive performances in patients affected by late-onset epilepsy with unknown etiology: A 12-month follow-up study 248
Cerebrospinal Fluid Orexin Levels and Nocturnal Sleep Disruption in Alzheimer's Disease Patients Showing Neuropsychiatric Symptoms 246
CSF levels of the endocannabinoid anandamide are reduced in patients with untreated narcolepsy type 1: a pilot study 245
Lacosamide may improve cognition in patients with focal epilepsy: EpiTrack to compare cognitive side effects of lacosamide and carbamazepine 240
Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 238
Lower instantaneous entropy of heartbeat dynamics during seizures in untreated temporal lobe epilepsy 229
Seasonality of restless legs syndrome: symptom variability in winter and summer times 214
Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies 198
Preliminary evidence about irritability in patients with epilepsy treated by perampanel as first add-on therapy compared to levetiracetam and valproic acid 193
Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer’s disease 186
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation 185
Preliminary evidence that vortioxetine may improve sleep quality in depressed patients with insomnia: a retrospective questionnaire analysis 176
Obstructive sleep apnea is associated with early but possibly modifiable Alzheimer's disease biomarkers changes 168
Pitolisant for treating narcolepsy comorbid with Parkinson's disease 166
18F-FDG PET, cognitive functioning, and CSF biomarkers in patients with obstructive sleep apnoea before and after continuous positive airway pressure treatment 163
Assessment of self-reported and objective daytime sleepiness in adult-onset myotonic dystrophy type 1 149
The actigraphic documentation of circadian sleep-wake rhythm dysregulation in myotonic dystrophy type 1 147
Heart rate variability parameters during psychogenic non-epileptic seizures: comparison between patients with pure PNES and comorbid epilepsy 137
New revolution in the assessment of cerebrospinal fluid orexin-A: Enzyme-linked immunosorbent assay! 136
Autonomic symptoms, cardiovascular and sudomotor evaluation in de novo type 1 narcolepsy 119
Autonomic functions in focal epilepsy: A comparison between lacosamide and carbamazepine monotherapy 113
Levetiracetam, lamotrigine and carbamazepine: which monotherapy during pregnancy? 106
Cerebrospinal-fluid biomarkers for predicting phenoconversion in patients with isolated rapid-eye movement sleep behavior disorder 101
Obstructive sleep apnea syndrome and Alzheimer's disease pathology: may continuous positive airway pressure treatment delay cognitive deterioration? 97
Cognitive and Neuropsychiatric Profiles in Idiopathic Rapid Eye Movement Sleep Behavior Disorder and Parkinson's Disease. 95
Sleep-wake cycle dysregulation in idiopathic REM sleep behaviour disorder 91
Correction to: Sleep dysregulation, memory impairment, and CSF biomarkers during different levels of neurocognitive functioning in Alzheimer's disease course 91
Nocturnal hypoxia and sleep fragmentation may drive neurodegenerative processes: the compared effects of obstructive sleep apnea syndrome and periodic limb movement disorder on Alzheimer's disease biomarkers 88
Neuroimaging findings in leukoencephalopathy with calcifications and cysts: case report and review of the literature 87
Derivation and Validation of a Phenoconversion-Related Pattern in Idiopathic Rapid Eye Movement Behavior Disorder 84
Brivaracetam as early add-on treatment in patients with focal seizures: a retrospective, multicenter, real-world study 81
Clinical characteristics of a large cohort of patients with narcolepsy candidate for pitolisant: a cross-sectional study from the Italian PASS Wakix® Cohort 80
Perampanel may represent an effective treatment for the prevention of migraine comorbid with epilepsy 77
Periodic sharp wave complexes identify a distinctive phenotype in Creutzfeldt-Jacob disease. 76
Insular monoaminergic deficits in prodromal α-synucleinopathies 68
Brainstem impairment in obstructive sleep apnoea and the effect of CPAP treatment: an electrophysiological blink reflex study 68
A preliminary study investigating the clinical potential of measuring cerebrospinal-fluid lactate levels in patients with narcolepsy type 1 and 2 64
Depressive symptoms in patients with epilepsy and clinically associated features in a single tertiary center 63
Continuous positive airway pressure treatment improves bone mineral density in men affected by severe obstructive sleep apnea syndrome 58
More than sleep and wake disturbances: An actigraphic study showing the sleep-wake pattern dysregulation in epilepsy 56
Sleep Dysregulation Is Associated with 18F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease 55
Neuropsychiatric, neuropsychological, and neuroimaging features in isolated REM sleep behavior disorder: The importance of MCI 55
Effectiveness of Highly Purified Cannabidiol in Refractory and Super-Refractory Status Epilepticus: A Case Series 49
Generalized Fast Discharges Along the Genetic Generalized Epilepsy Spectrum: Clinical and Prognostic Significance 46
OBSTRUCTIVE SLEEP APNEA AS A RISK FACTOR FOR OSTEOPENIA AND OSTEOPOROSIS IN THE MALE POPULATION 39
null 7
Totale 14.282
Categoria #
all - tutte 44.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202191 0 0 0 0 0 0 0 0 0 0 68 23
2021/2022661 27 46 26 11 16 18 65 15 33 53 40 311
2022/2023846 103 77 39 104 69 174 65 53 84 16 37 25
2023/2024443 43 10 24 23 36 146 21 37 8 27 6 62
2024/20251.391 62 286 148 97 36 121 67 67 142 122 140 103
2025/20262.685 251 80 332 301 243 124 398 323 328 291 14 0
Totale 14.282